Kasper, B.; Pink, D.; Rothermundt, C.; Richter, S.; Augustin, M.; Kollar, A.; Kunitz, A.; Eisterer, W.; Gaidzik, V.; Brodowicz, T.;
et al. Geriatric Assessment of Older Patients Receiving Trabectedin in First-Line Treatment for Advanced Soft Tissue Sarcomas: The E-TRAB Study from The German Interdisciplinary Sarcoma Group (GISG-13). Cancers 2024, 16, 558.
https://doi.org/10.3390/cancers16030558
AMA Style
Kasper B, Pink D, Rothermundt C, Richter S, Augustin M, Kollar A, Kunitz A, Eisterer W, Gaidzik V, Brodowicz T,
et al. Geriatric Assessment of Older Patients Receiving Trabectedin in First-Line Treatment for Advanced Soft Tissue Sarcomas: The E-TRAB Study from The German Interdisciplinary Sarcoma Group (GISG-13). Cancers. 2024; 16(3):558.
https://doi.org/10.3390/cancers16030558
Chicago/Turabian Style
Kasper, Bernd, Daniel Pink, Christian Rothermundt, Stephan Richter, Marinela Augustin, Attila Kollar, Annegret Kunitz, Wolfgang Eisterer, Verena Gaidzik, Thomas Brodowicz,
and et al. 2024. "Geriatric Assessment of Older Patients Receiving Trabectedin in First-Line Treatment for Advanced Soft Tissue Sarcomas: The E-TRAB Study from The German Interdisciplinary Sarcoma Group (GISG-13)" Cancers 16, no. 3: 558.
https://doi.org/10.3390/cancers16030558
APA Style
Kasper, B., Pink, D., Rothermundt, C., Richter, S., Augustin, M., Kollar, A., Kunitz, A., Eisterer, W., Gaidzik, V., Brodowicz, T., Egerer, G., Reichardt, P., Hohenberger, P., & Schuler, M. K.
(2024). Geriatric Assessment of Older Patients Receiving Trabectedin in First-Line Treatment for Advanced Soft Tissue Sarcomas: The E-TRAB Study from The German Interdisciplinary Sarcoma Group (GISG-13). Cancers, 16(3), 558.
https://doi.org/10.3390/cancers16030558
